CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
RMCF
Rocky Mountain Chocolate Factory, Inc.
There isn't enough reported data to score RMCF yet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
RMCF Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Strong |
RMCF's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
RMCF PE Valuation
RMCF has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
RMCF Forward outlook
There aren't enough analyst estimates for RMCF to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over RMCF on earnings quality, reporting a profit while its opponent remains loss making.
RMCF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.69 | -$0.07 |
| Q2 2026 | -$0.64 | $0.00 |
| Q1 2026 | -$0.56 | +$0.30 |
| Q4 2025 | -$0.53 | +$0.20 |
| Q3 2025 | -$0.62 | +$0.12 |
| Q2 2025 | -$0.64 | +$0.15 |
| Q1 2025 | -$0.86 | -$0.20 |
| Q4 2024 | -$0.73 | -$0.05 |
RMCF is still losing money, but less than at its worst: $0.69 per share over the past year, against $1.02 at its worst in mid-2023.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over RMCF on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over RMCF on profitability, with a higher operating margin.
RMCF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.7M | -2.5% |
| Q2 2026 | $6.1M | -4.1% |
| Q1 2026 | $6.8M | -24% |
| Q4 2025 | $7.5M | -4.4% |
| Q3 2025 | $6.8M | +6.9% |
| Q2 2025 | $6.4M | -0.5% |
| Q1 2025 | $8.9M | +23% |
| Q4 2024 | $7.9M | +2.5% |
RMCF's revenue has slid since its 2022 peak: $7M last quarter, down 2.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -16% | -9.3 points |
| Q2 2026 | -16% | -14 points |
| Q1 2026 | -45% | -15 points |
| Q4 2025 | 1.1% | +10 points |
| Q3 2025 | -7% | +7.3 points |
| Q2 2025 | -2.3% | +23 points |
| Q1 2025 | -30% | -8.6 points |
| Q4 2024 | -8.9% | +1.2 points |
RMCF's operating margin was −16% last quarter, down 9.3 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over RMCF on cash generation, producing positive trailing cash flow while its opponent burns cash.
RMCF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$138K | +$406K |
| Q2 2026 | -$604K | -432% |
| Q1 2026 | -$739K | -$319K |
| Q4 2025 | -$1.3M | +$1.5M |
| Q3 2025 | -$544K | +$4.1M |
| Q2 2025 | $182K | +$2.8M |
| Q1 2025 | -$420K | -$149K |
| Q4 2024 | -$2.7M | +$148.4K |
RMCF has burned cash in most quarters: −$3M over the past year, against −$4M the year before.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over RMCF on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
RMCF Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +56.9K shares |
| 1 year | +21% | +1.7M shares |
| 3 years | +50% | +3.2M shares |
| 5 years | +50% | +3.2M shares |
| Available history | +58% | +3.5M shares |
RMCF has 9M diluted shares, up 21% from a year ago.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
RMCF Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2022 | -10.5x | Net Cash |
| Q4 2021 | -5.9x | Net Cash |
| Q3 2021 | -2.0x | Net Cash |
| Q2 2021 | -1.8x | Net Cash |
| Q1 2020 | -1.7x | Net Cash |
| Q4 2019 | -1.3x | Net Cash |
RMCF has more cash than debt.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
RMCF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 9.8 | Oversold |
RMCF's weekly RSI is 33 (neutral) and its Stochastic is 10 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
RMCF PE vs Consumer Defensive Sector
| Metric | RMCF | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
RMCF has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over RMCF on trend strength, trading above more of its moving averages.
RMCF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.87 | 15% below |
| 20 week MA | $0.95 | 22% below |
| 50 week MA | $1.63 | 55% below |
| 100 week MA | $1.63 | 55% below |
| 200 week MA | $2.80 | 74% below |
RMCF is in a downtrend: it's below all five of its weekly moving averages, and 74% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over RMCF on returns for 2026, with the stronger performance.
RMCF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.10 | $4.07 | -55% |
| 2021 | $4.07 | $8.28 | +103% |
| 2022 | $8.28 | $5.87 | -29% |
| 2023 | $5.87 | $4.60 | -22% |
| 2024 | $4.60 | $2.40 | -48% |
| 2025 | $2.40 | $1.94 | -19% |
| 2026 YTD | $1.94 | $0.74 | -62% |
RMCF has finished four years in a row lower, and it's down 62% so far in 2026.